More OB/GYNs, NPs need to be screening for colorectal cancer
Although about 95% of obstetricians/gynecologists and nurse practitioners (NPs) screen their female patients for breast and cervical cancer, only bout 75% screen for colorectal cancer (CRC), according to the findings of a recent study.
Although about 95% of obstetricians/gynecologists (ob/gyns) and nurse practitioners (NPs) screen their female patients for breast and cervical cancer, only about 75% screen for colorectal cancer (CRC), according to the findings of a recent study.
Researchers mailed a survey to 1,130 ob/gyns and NPs. Not quite one-third (29.7%) returned the completed survey. Of those, 54% came from ob/gyns, and 46% came from NPs.
The survey revealed that routine CRC screening was about 30% more common among ob/gyns than among NPs (87.2% vs 61.7%, respectively; p<.001). Slightly more than half of both types of providers identified the correct age at which to begin screening, but, overall, ob/gyns scored higher than NPs on questions regarding CRC screening.
Menees SB, Patel DA, Dalton V. Colorectal cancer screening practices among obstetrician/gynecologists and nurse practitioners. J Womens Health. 2009;18(8):1233-1238.
Thinner endometrial thickness linked to higher placenta accreta spectrum risk
November 29th 2024A recent study reveals that reduced endometrial thickness significantly increases the risk of placenta accreta spectrum disorders in women without prior cesarean deliveries using assisted reproductive technology.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More
